|
A phase 1/2 study of continuous infusion ifosfamide/mesna + aldoxorubicin in sarcoma patients. |
| |
|
Research Funding - CytRx Corporation (Inst) |
Travel, Accommodations, Expenses - CytRx Corporation |
| |
|
No Relationships to Disclose |
| |
|
Employment - CytRx Corporation |
Stock and Other Ownership Interests - CytRx Corporation |
Research Funding - CytRx Corporation (Inst) |
Travel, Accommodations, Expenses - CytRx Corporation |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Employment - CytRx Corporation |
Stock and Other Ownership Interests - CytRx Corporation |
| |
|
Employment - CytRx Corporation |
Leadership - CytRx Corporation |
Stock and Other Ownership Interests - CytRx Corporation |
| |
|
No Relationships to Disclose |